CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Planned sale Chief Innovation/Tech Officer sold 50,000 shares at $6.00 ($300,000)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4 Shares withheld for taxes President and CEO gave up 37,938 shares (to pay taxes)
- 4 Shares withheld for taxes See Remark gave up 8,370 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 10,530 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 11,705 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Research & Development gave up 12,956 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Operations gave up 9,432 shares (to pay taxes)
- 4 Planned sale Chief Innovation/Tech Officer sold 25,000 shares at $5.19 ($129,685)
- 4 Grant or award SVP, General Counsel acquired 135,000 shares (grant or award)
- 4 Grant or award SVP, Chief Financial Officer acquired 120,000 shares (grant or award)
- 4 Grant or award Chief Innovation/Tech Officer acquired 82,500 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 112,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 242,600 shares (grant or award)
- 4 Grant or award SVP, Operations acquired 101,250 shares (grant or award)
- 4 Grant or award See Remark acquired 86,250 shares (grant or award)
Page 12 of 35 · 690 filings